TORONTO, Aug. 2, 2018 /CNW/ - Aleafia Health Inc.
(TSXV: ALEF) (OTCQX: ALEAF) ("Aleafia") or (the
"Company"), is pleased to announce the appointment of
senior finance executive Benjamin
Ferdinand as the company's new Chief Financial Officer.
Benjamin joins Aleafia from TMX Group ("TMX"), the parent
company of the Toronto Stock Exchange, where he led TMX's firmwide
platform initiatives as Managing Director, Platform Strategies.
Previously, Benjamin served as Vice-President and Head of Finance,
Strategy and Corporate Development for TMX.
Benjamin will assume the CFO role on August 20, 2018, with current CFO Garry Stewart remaining in the role until that
time.
Reporting directly to the CEO, he will have responsibility for
the firm's overall strategic direction, financial reporting and
planning, investor relations, treasury, controller's operations and
corporate development.
Among his achievements while at TMX, Benjamin led the
$930 million acquisition of Trayport
Holdings Ltd., a world-leading provider of technology solutions for
energy traders, brokers and exchanges, from Intercontinental
Exchange Inc. (financed with a $390
million capital raise, cash and asset sales).
"It is an honour to join a company with such strong fundamentals
and significant potential for growth. In a competitive marketplace,
Aleafia is well-positioned to differentiate itself as Canada's leading medicinal cannabis company
and to deliver long-term value to our patients and shareholders,"
said Benjamin.
"Benjamin will play a critical role in this exciting period in
Aleafia's history," said Aleafia's CEO, Geoff Benic. "I would also like to thank
Garry Stewart for his dedication and
service to the company."
Benjamin began his career in investment banking, both in
Toronto and New York. He holds a Master of Business
Administration (MBA) from Ivey Business School at the University of Western Ontario and a Bachelor of
Commerce from McMaster University.
Benjamin entered into an executive employment agreement with the
Company pursuant to which he was granted, as partial compensation,
an aggregate of 600,000 stock options under the Company`s stock
option plan of which 125,000 stock options vest every six months
over a 2 year period (Time Based Options) and 100,000 vest upon the
completion of various performance milestones as determined by the
Board (Performance Based Options). All options are at an exercise
price of $0.65 with a five year
term.
Aleafia is also pleased to announce the appointment of
Nicholas Bergamini as
Vice-President, Public Affairs. Prior to joining Aleafia, Nicholas
served as the Press Secretary and Director of Communications to the
Leader of the Official Opposition in the Ontario Legislature.
Previously, he served as the Press Secretary and Chief Spokesman
for Canada's Minister of
Finance.
Nicholas entered into an executive employment agreement with the
Company pursuant to which he was granted, as partial compensation,
an aggregate of 300,000 stock options under the Company`s stock
option plan of which 62,500 stock options vest every six months
over a 2 year period (Time Based Options) and 50,000 vest upon the
completion of various performance milestones as determined by the
Board (Performance Based Options). All options are at an exercise
price of $0.65 with a five year
term.
About Aleafia Health Inc.:
Aleafia is a leading, vertically integrated medical cannabis
company with a unique focus on delivering quality patient care from
"seed" to "sale." Aleafia is uniquely positioned with a singular
focus on the medical cannabis market. The company operates the
largest brick and mortar medicinal cannabis clinic network in
Canada under the Canabo Medical
Clinic brand, which is staffed by licensed, practicing physicians.
Aleafia has obtained over 50,000 unique patients and maintains the
largest medical cannabis patient data set in Canada. Aleafia's state of the art production
facilities will allow for the production of high- quality strains
at low cost. Aleafia's production will focus on securing the
highest- quality medicinal product for its growing patient
base.
Neither Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the Exchange) accepts
responsibility for the adequacy or accuracy of this release.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements and
information that are based on the beliefs of management and reflect
the Company's current expectations. When used in this press
release, the words "estimate", "project", "belief", "anticipate",
"intend", "expect", "plan", "predict", "may" or "should" and the
negative of these words or such variations thereon or comparable
terminology are intended to identify forward-looking statements and
information. The forward-looking statements and information
in this press release includes information relating to the
implementation of Aleafia Health's business plan. Such
statements and information reflect the current view of the Company
with respect to risks and uncertainties that may cause actual
results to differ materially from those contemplated in those
forward-looking statements and information.
By their nature, forward-looking statements involve known and
unknown risks, uncertainties and other factors which may cause our
actual results, performance or achievements, or other future
events, to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. Such factors include, among
others, the following risks: risks associated with the
implementation of Aleafia Health's business plan and matters
relating thereto, risks associated with the cannabis industry,
competition, regulatory change, the need for additional financing,
reliance on key personnel, the potential for conflicts of interest
among certain officers or directors, and the volatility of the
Company's common share price and volume. Forward-looking
statements are made based on management's beliefs, estimates and
opinions on the date that statements are made and the Company
undertakes no obligation to update forward-looking statements if
these beliefs, estimates and opinions or other circumstances should
change. Investors are cautioned against attributing undue
certainty to forward-looking statements.
SOURCE Aleafia Inc.